TRACON Pharmaceuticals Buy Hold or Sell Recommendation
| TCONDelisted Stock | USD 1.60 0.55 52.38% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding TRACON Pharmaceuticals is 'Not Rated'. The recommendation algorithm takes into account all of TRACON Pharmaceuticals' available fundamental, technical, and predictive indicators you will find on this site.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. In addition, we conduct extensive research on individual companies such as TRACON and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards TRACON Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
TRACON |
Execute TRACON Pharmaceuticals Buy or Sell Advice
The TRACON recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on TRACON Pharmaceuticals. Macroaxis does not own or have any residual interests in TRACON Pharmaceuticals or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute TRACON Pharmaceuticals' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
TRACON Pharmaceuticals Trading Alerts and Improvement Suggestions
| TRACON Pharmaceuticals is not yet fully synchronised with the market data | |
| TRACON Pharmaceuticals may become a speculative penny stock | |
| TRACON Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 12.04 M. Net Loss for the year was (3.59 M) with loss before overhead, payroll, taxes, and interest of (13.89 M). |
TRACON Pharmaceuticals current analysts advice
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. TRACON analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. TRACON analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.
TRACON Pharmaceuticals Returns Distribution Density
The distribution of TRACON Pharmaceuticals' historical returns is an attempt to chart the uncertainty of TRACON Pharmaceuticals' future price movements. The chart of the probability distribution of TRACON Pharmaceuticals daily returns describes the distribution of returns around its average expected value. We use TRACON Pharmaceuticals price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of TRACON Pharmaceuticals returns is essential to provide solid investment advice for TRACON Pharmaceuticals.
| Mean Return | -1.84 | Value At Risk | -17.77 | Potential Upside | 19.59 | Standard Deviation | 11.21 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of TRACON Pharmaceuticals historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Note: Acquisition by Charles Theuer of 3500 shares of TRACON Pharmaceuticals at 0.1333 subject to Rule 16b-3 [view details]
TRACON Pharmaceuticals Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as TRACON . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About TRACON Pharmaceuticals Buy or Sell Advice
When is the right time to buy or sell TRACON Pharmaceuticals? Buying financial instruments such as TRACON Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having TRACON Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Biotech Thematic Idea Now
Biotech
Companies specialized in biotechnology production and delivery of pharmaceuticals services. The Biotech theme has 47 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Biotech Theme or any other thematic opportunities.
| View All Next | Launch |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Consideration for investing in TRACON Stock
If you are still planning to invest in TRACON Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the TRACON Pharmaceuticals' history and understand the potential risks before investing.
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |